Ophthalmology

Top Story

Early response to anti-VEGF therapy for DME may predict 3-year outcome

May 5, 2016

SEATTLE — Optimal and suboptimal early responses to anti-VEGF therapy tended to predict long-term outcomes in patients treated for diabetic macular edema, according to data presented at the Association for Research in Vision and Ophthalmology meeting.

In an interview with Ocular Surgery News, Scott M. Whitcup, MD, discussed results of a post hoc analysis of data from the DRCR.net Protocol I study.

Ab interno canaloplasty reduces IOP, medication use in patients with primary open-angle glaucoma

May 4, 2016
Ab interno canaloplasty reduced IOP and medication use in patients with primary open-angle glaucoma, according to a press release from Ellex Medical Lasers.Ellex…
In the Journals

Gene therapy improves VA in eyes treated for choroideremia

May 4, 2016
An adeno-associated virus vector improved visual function in two of six patients treated for choroideremia, according to a letter published in the New England Journal of
Meeting News CoverageVideo

VIDEO: Researchers work to improve vision achieved with retinal prostheses

May 4, 2016
SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Andrew Weitz, MD, of the USC Roski Eye Institute, describes research underway to improve…
Meeting News CoverageVideo

VIDEO: Connectomics used to aggregate data on effects of low vision on visual pathways

May 4, 2016
SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, James Weiland, MD, of the USC Roski Eye Institute, describes connectomics in low vision, a…
More News Headlines »
Clinical Science

En Face Spectral-Domain Optical Coherence Tomography Imaging of Outer Retinal Hard Exudates in Diabetic Macular Edema Based on Optical Coherence Tomography Patterns

Ophthalmic Surgery, Lasers and Imaging Retina, April 2016, Volume 47 Issue 4
To evaluate en face spectral-domain optical coherence tomography (SD-OCT) findings of the outer retinal hard exudates…
More »
CME

Comparative Treatment Trials for Wet AMD: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ARVO

Highlights from ARVO

Video
Meeting News Coverage

VIDEO: Connectomics used to aggregate data on effects of low vision on visual pathways

May 4, 2016
More »
morganatic-roan morganatic-roan